Literature DB >> 6791229

Increased food and water intake produced in rats by opiate receptor agonists.

D J Sanger, P S McCarthy.   

Abstract

It has been suggested that endogenous opiate mechanisms may be involved in the physiological control of food and water intake. Support for this hypothesis has been obtained from studies of the effects of narcotic antagonists which reduce feeding and drinking, but it is also necessary to show that food and water intake can be facilitated by opiate agonists. In the present study the food intake of freely-feeding rats was increased by subcutaneous injections of morphine, a stabilised enkephalin and analogue (RX 783030), and ethylketocyclazocine. Water intake was also increased but this effect was more variable than the increased eating. The increased food intake produced by the putative mu receptor agonists morphine and RX 783030 was blocked by a dose of naloxone which did not affect the facilitation of eating produced by ethylketocyclazocine, which may act at a separate population of receptors known as kappa receptors. These data are consistent with the possibility that opiate receptors are involved in the control of feeding and drinking.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6791229     DOI: 10.1007/BF00427097

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  30 in total

1.  The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog.

Authors:  W R Martin; C G Eades; J A Thompson; R E Huppler; P E Gilbert
Journal:  J Pharmacol Exp Ther       Date:  1976-06       Impact factor: 4.030

2.  Behavioral effects of separate and combined administration of naloxone and d-amphetamine.

Authors:  S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1974-04       Impact factor: 4.030

3.  Changes in core temperature and feeding in rats by levorphanol and dextrorphan.

Authors:  J A Thornhill; M Hirst; C W Gowdey
Journal:  Can J Physiol Pharmacol       Date:  1979-09       Impact factor: 2.273

4.  The effects of opiate antagonists on food intake are stereospecific.

Authors:  D J Sanger; P S McCarthy; G Metcalf
Journal:  Neuropharmacology       Date:  1981-01       Impact factor: 5.250

5.  Disturbed patterns of behaviour in morphine tolerant and abstinent rats.

Authors:  R Kumar; E Mitchell; I P Stolerman
Journal:  Br J Pharmacol       Date:  1971-07       Impact factor: 8.739

6.  Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior.

Authors:  R A Harris
Journal:  J Pharmacol Exp Ther       Date:  1980-06       Impact factor: 4.030

7.  beta-Endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa).

Authors:  D L Margules; B Moisset; M J Lewis; H Shibuya; C B Pert
Journal:  Science       Date:  1978-12-01       Impact factor: 47.728

8.  Tolerance and evidence of physical dependence to daily codeine injections in the rat.

Authors:  J A Thornhill; M Hirst; C W Gowdey
Journal:  Pharmacol Biochem Behav       Date:  1978-10       Impact factor: 3.533

9.  Classification of opioids on the basis of change in seizure threshold in rats.

Authors:  A Cowan; E B Geller; M W Adler
Journal:  Science       Date:  1979-10-26       Impact factor: 47.728

10.  Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors.

Authors:  B K Handa; A C Land; J A Lord; B A Morgan; M J Rance; C F Smith
Journal:  Eur J Pharmacol       Date:  1981-04-09       Impact factor: 4.432

View more
  21 in total

1.  Effects of mu opioid receptor antagonism on cognition in obese binge-eating individuals.

Authors:  Samuel R Chamberlain; Karin Mogg; Brendan P Bradley; Annelize Koch; Chris M Dodds; Wenli X Tao; Kay Maltby; Bhopinder Sarai; Antonella Napolitano; Duncan B Richards; Edward T Bullmore; Pradeep J Nathan
Journal:  Psychopharmacology (Berl)       Date:  2012-07-03       Impact factor: 4.530

2.  Intracerebral injection of different antibodies against endogenous opioids suggests alpha-neoendorphin participation in control of feeding behaviour.

Authors:  R Schulz; A Wilhelm; G Dirlich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-06       Impact factor: 3.000

Review 3.  Song practice as a rewarding form of play in songbirds.

Authors:  Lauren V Riters; Jeremy A Spool; Devin P Merullo; Allison H Hahn
Journal:  Behav Processes       Date:  2017-10-12       Impact factor: 1.777

4.  Ingestive behaviour of the pigeon: stereoselective influence of the opiate agonist levorphanol and its antagonism by naloxone.

Authors:  P Deviche; G Schepers
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

5.  An analysis of the effects of systemically administered clonidine on the food and water intake of rats.

Authors:  D J Sanger
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

6.  Predictors of thirst in intensive care unit patients.

Authors:  Nancy A Stotts; Shoshana R Arai; Bruce A Cooper; Judith E Nelson; Kathleen A Puntillo
Journal:  J Pain Symptom Manage       Date:  2014-08-10       Impact factor: 3.612

7.  Naloxone treatment attenuates food but not water intake in domestic pigeons.

Authors:  P Deviche; G Schepers
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Stimulation of food intake following opiate agonists in rats but not hamsters.

Authors:  M T Lowy; G K Yim
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  Common effects of fat, ethanol, and nicotine on enkephalin in discrete areas of the brain.

Authors:  G-Q Chang; O Karatayev; J R Barson; S C Liang; S F Leibowitz
Journal:  Neuroscience       Date:  2014-07-30       Impact factor: 3.590

10.  Chronic intracerebroventricular morphine and lactation in rats: dependence and tolerance in relation to oxytocin neurones.

Authors:  V C Rayner; I C Robinson; J A Russell
Journal:  J Physiol       Date:  1988-02       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.